Although previous reports have suggested that NfH levels may be a candidate biomarker for ALS and other progressive neurodegenerative diseases including AD and PD [21], [22], [27], [35], most of these studies have examined CSF as the target biological fluid. This evidence concerns the gene NEFH and amyotrophic lateral sclerosis.